Literature DB >> 9457254

An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer.

I Uzoaru1, M Rubenstein, Y Mirochnik, L Slobodskoy, M Shaw, P Guinan.   

Abstract

BACKGROUND AND OBJECTIVES: p53 and Ki-67 are but two markers being evaluated for their predictive value in prostate cancer. The purpose of this study was to compare p53 and Ki-67 with age, stage, Gleason score, and ploidy for their prognostic abilities in prostate cancer.
METHODS: Prostate cancer specimens from 134 patients were immunohistochemically stained for p53 and Ki-67 expression and differences evaluated by SPSS analysis of variance (ANOVA) methods. The dependent variable was patient survival and the independent variables were age, stage, Gleason score, and ploidy.
RESULTS: In decreasing order of prediction of survival were stage (P < 0.001), Gleason score (P < 0.001), age (P = 0.1869), Ki-67 (P = 0.2284), p53 (P = 0.4282) and ploidy (P = 0.8141).
CONCLUSION: It is concluded that stage and Gleason score are significant predictors of survival while p53, Ki-67, age and ploidy are not.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9457254     DOI: 10.1002/(sici)1096-9098(199801)67:1<33::aid-jso7>3.0.co;2-n

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia.

Authors:  Jean-Marie Bruey; Hagop Kantarjian; Wanlong Ma; Zeev Estrov; Chenhsiung Yeh; Amber Donahue; Heather Sanders; Susan O'Brien; Michael Keating; Maher Albitar
Journal:  Leuk Res       Date:  2010-04-01       Impact factor: 3.156

2.  In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.

Authors:  Anthonius J Breeuwsma; Jan Pruim; Maud M Jongen; Albert J Suurmeijer; Wim Vaalburg; Rien J Nijman; Igle J de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-12       Impact factor: 9.236

3.  The prognostic value of p53 and DNA ploidy following radical prostatectomy.

Authors:  C Deliveliotis; A Skolarikos; A Karayannis; V Tzelepis; N Trakas; E Alargof; V Protogerou
Journal:  World J Urol       Date:  2003-07-03       Impact factor: 4.226

4.  Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.

Authors:  Jean-Marie Bruey; Hagop Kantarjian; Zeev Estrov; Zhong Zhang; Wanlong Ma; Ferras Albitar; Adam Abdool; Deborah Thomas; Chenhsiung Yeh; Susan O'Brien; Maher Albitar
Journal:  Leuk Res       Date:  2009-08-12       Impact factor: 3.156

5.  Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer.

Authors:  Christoph Burdelski; Aleksandra Matuszewska; Martina Kluth; Christina Koop; Katharina Grupp; Stefan Steurer; Corinna Wittmer; Sarah Minner; Maria Christina Tsourlakis; Guido Sauter; Thorsten Schlomm; Ronald Simon
Journal:  Microarrays (Basel)       Date:  2014-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.